Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Joyce

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Blood|May 3, 2019
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoffrey D E Cuvelier, Eneida R Nemecek, Justin T Wahlstrom, et al.
Blood|February 13, 2020
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R Schultz, Amina Kariminia, Bernard Ng, et al.
Blood|January 29, 2021
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of functionJahnavi Aluri, Alicia Bach, Saara Kaviany, et al.
Blood|October 8, 2025
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell TransplantationBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Transplantation and Cellular Therapy|October 1, 2025
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study CohortBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Blood|May 3, 2019
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoffrey D E Cuvelier, Eneida R Nemecek, Justin T Wahlstrom, et al.
Blood|February 13, 2020
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R Schultz, Amina Kariminia, Bernard Ng, et al.
Blood|January 29, 2021
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of functionJahnavi Aluri, Alicia Bach, Saara Kaviany, et al.
Blood|October 8, 2025
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell TransplantationBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Transplantation and Cellular Therapy|October 1, 2025
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study CohortBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Pageof 9